drugset / Trial / NCT00936559

Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair

NCT00936559 ↗

Phase 1 Terminated 13 enrolled Pfizer
RandomizedSingle-groupSingle-blindTreatment

Summary

Study to assess the safety of 3 differing concentrations of BMP-655/ACS in subjects with full thickness Rotator Cuff Tears (RCTs).

Timeline

Start
2010-09
Primary completion
2012-02
Completion
2012-02

Outcome

Outcome not reported

Stopped: “See termination reason in detailed description.”

Drugs

EvaluationDrugModalityDoseRoute
Subject rhBMP-12 Protein / enzyme biologic — —

Indications